US7223610B2 - Direct phosphorylation state monitoring on biomolecules - Google Patents

Direct phosphorylation state monitoring on biomolecules Download PDF

Info

Publication number
US7223610B2
US7223610B2 US10/820,404 US82040404A US7223610B2 US 7223610 B2 US7223610 B2 US 7223610B2 US 82040404 A US82040404 A US 82040404A US 7223610 B2 US7223610 B2 US 7223610B2
Authority
US
United States
Prior art keywords
biomolecules
accordance
fluorescence lifetime
sample
fluorescent marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US10/820,404
Other languages
English (en)
Other versions
US20040259183A1 (en
Inventor
Klaus Doering
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecan Trading AG
Original Assignee
Tecan Trading AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecan Trading AG filed Critical Tecan Trading AG
Assigned to TECAN TRADING AG reassignment TECAN TRADING AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DOERING, KLAUS
Publication of US20040259183A1 publication Critical patent/US20040259183A1/en
Application granted granted Critical
Publication of US7223610B2 publication Critical patent/US7223610B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Definitions

  • the invention relates to a method for measuring chemical groups attached to biological molecules, in particular for measuring the presence or absence of phosphate groups attached to biological molecules.
  • the classes of enzymes which catalyze the attachment (phosphokinase) and/or the removal (phosphatase) of phosphate residues to and from biomolecules is of great biological and pharmacological importance.
  • concentration of reactants or products of the reaction that is for instance, the quantity of phosphorylated biomolecules in the sample volume.
  • fluorescence polarization measurements are based on changes in the volume of the molecules subject to measurement.
  • Many of the reactions involving biological processes based on an increase in volume such as those involving receptor-ligand bonds, antibody-antigen bonds, DNA hybridization or DNA protein bonds, as well as those processes involving a reduction in volume, such as enzymatic degradation or dissociation reactions, can be measured directly by means of fluorescence polarization.
  • Such tests employ the following approach: An unphosphorylated biomolecule is incubated with an enzyme which binds a phosphate group to this molecule, namely with a phosphokinase, or a phosphorylated peptide is incubated with an enzyme that removes the phosphate group from this peptide, that is with a phosphatase.
  • the change in the volume of a biological molecule by adding or removing a small chemical group, such as for instance a phosphate, sulfate or oxalate group is not significant enough for it to be detected directly by means of fluorescence polarization.
  • a small chemical group such as for instance a phosphate, sulfate or oxalate group
  • auxiliary molecules in the form of antibodies, have to be selected in such a way that they only ever form a bond with the peptides being analyzed when these peptides truly include a phosphate group. This ensures that there is a significant difference in terms of their volume between the phosphopeptide/antibody complexes being measured by means of fluorescence polarization and the non-phosphorylated peptides without any attached auxiliary molecules.
  • This commercially available approach was originally developed to provide a non-destructive marker which facilitated the tracking of enzyme functionality. In a situation in which the pharmacological efficacy of chemical substances is being tested (i.e. a drug discovery situation), such assay substances are added to the system, with the standardized fluorescence polarization measurement providing information as to whether the assay substance produces the desired modulation effect on the enzyme or not.
  • auxiliary molecules such as the method for instance disclosed in U.S. Pat. No. 6,410,255.
  • other chemical compounds can also be employed as the auxiliary molecules for detecting the phosphorylation of a biomolecule, thus being capable of differentiating one state of phosphorylation from another. If one were to attempt to measure the concentration of other reactants or products of a phosphorylation reaction using an alternative method, one would have to employ chemical methods involving more complex additions than is the case with fluorescence polarization.
  • an alternative method for detecting a chemical reaction at a biological molecule in a simple manner, such as for instance phosphorylation or dephosphorylation of a peptide.
  • the present invention is based upon the unexpected and surprising discovery that by adding or removing a phosphate group to or from a biological molecule respectively, the fluorescent lifetime of fluorophores attached to these samples, reflecting the presence or absence of a phosphate group, is altered significantly.
  • the mechanism upon which the present invention is based is not fully understood. However, it is assumed that it involves an interaction between the fluorescent marker and a charged residue, which is attached in the vicinity of the binding site of the fluorescent marker on the same biomolecule and/or is located within the spatial range of the fluorescent marker.
  • Fluorescein was found to be a fluorescent marker, the fluorescence lifetime of which changes significantly in response to the presence or absence of a phosphate group.
  • the invention encompasses not only the use of fluorescein; the general assumption is made that every chemical reaction involving a biomolecule, which produces one or more charged chemical residues, can be detected properly by measuring the fluorescence lifetime. The assumption is made that such or similar results can also be used for establishing the presence of other enzyme reactions, if in accordance with the present invention, the fluorescence lifetime of suitable fluorescent markers attached to the corresponding biomolecules is measured.
  • Oxidoreductases catalyze redox reactions, with oxidation resulting in the loss of electrons and a reduction in the acquisition of electrons. Consequently, it is possible for instance, that the modification of a fluorescence lifetime signal can be observed for a fluorescent marker which is located in the direct vicinity of an active oxidoreductase site, indicating the migration of electrons through the various amino acid side chains within the enzyme or substrate during the catalytic transition.
  • This fluorescent chain has already been detected in Class I enzymes: the reduction of NAD + to NADH by means of dehydrogenases has shown that NAD + is not fluorescent, in contrast to NADH.
  • Transferases are enzymes which catalyze the transfer of a functional group from one substituent to another, which can occur within the same molecule or between different molecules.
  • Typical examples for this class are kinases, which transform ATP to a protein or peptide. Similar effects involving the fluorescence lifetime, such as for the phosphokinase reactions described below, can be expected for thiolases and other transferases.
  • Hydrolases are enzymes which catalyze the hydrolysis of carboxylic acid esters, hemiacetal ethers (glycosyl compounds), thioethers, amides (peptide bonds) and acid anhydrides. This group also includes the phosphatases, as they cleave a phosphate group into water. The information for Class I and II also applies with respect to this class.
  • Lyases are enzymes which catalyze the elimination or addition of chemical groups.
  • One example is the elimination of a CO group, known as decarboxylation.
  • decarboxylation Due to the fact that the decarboxylases generally give up a pair of electrons in order to catalyze the decarboxylation reaction, as a change to the “electronic signature” of the substrate can be anticipated during the course of the decarboxylation reaction, this class of reactions and/or enzymes should also be able to be analyzed using lifetime fluorometry.
  • Isomerases catalyze certain intramolecular rearrangements, such as racemization, epimerization, cis-trans-conversions and enol-keto-tautomerization. As massive electron movement is also expected during enol-keto-tautomerization, it should also be possible to measure a change in the fluorescence lifetime in this case.
  • Ligases are enzymes which catalyze a bond between molecules, using the energy they gain from cleaving the ATP (or a similar nucleoside triphosphate). This class includes, for instance, fatty acid synthetases and DNA polymerases. Similarly, an assumption can be made with respect to these enzymes that it is highly likely that a catalytic reaction produced by these enzymes will result in a significant change to the fluorescence lifetime of a fluorophore located in the vicinity of an enzyme's active site.
  • a single fluorescent marker suffices if it is located in the vicinity and/or in the sphere of influence of a chemically active group on the biomolecule.
  • One condition with respect to the fluorescent marker is that it reacts to an alteration in the charge density and/or the configuration in its direct molecular environment by altering its fluorescence lifetime. The signal generated in this manner is thus much more direct than the method representing the state of the art, which employs the addition and binding of auxiliary molecules.
  • a multiwell plate is defined in connection with the present invention as an arrangement of open or closed chambers. This arrangement is preferably regular and constitutes a grid-like array of sample containers or sample holders.
  • Known multiwell plates of this type are for instance the so-called microplates, with 96, 384 or 1536 wells arranged in a rectangular grid.
  • the samples do not necessarily have to be arranged in depressions. Smaller samples can be also be arranged on a flat surface in an array and be separated from each other simply by hydrophobic sections or small elevations.
  • all multiwell plates have in common that a large number of samples with addressable positions can be processed simultaneously or essentially simultaneously.
  • TCSPC time correlated single photon counting
  • the samples were prepared in black 384-well microplates from GREINER (GREINER Bio-One GmbH, Bad Haller Strasse 32, 4550 Kremsmünster, Austria) with a filled volume of 70 ⁇ l.
  • the enzyme concentration was 100 pM to 100 nM. Incubation was undertaken for 30 minutes.
  • the fluorescence lifetime was measured using an “Ultra Evolution” machine with the fluorescence lifetime (FLT) option from TECAN (TECAN Austria GmbH, Grödig, Salzburg, Austria).
  • the fluorescence laser operated at a wavelength of 440 nm and a repetition rate of 20 MHz.
  • the emission filter was set to a wavelength of 544 nm and a bandwidth of 25 nm and the integration period per well was one second.
  • FIG. 1 shows the measured fluorescence lifetime of the fluorescent marker fluorescein, which is part of the tracer peptide (biomolecule), as a function of the enzyme concentration.
  • the fluorescent marker fluorescein which is part of the tracer peptide (biomolecule)
  • the enzyme PTP1B was added to the tracer peptide.
  • the fluorescence lifetime reflects the state of peptide phosphorylation, with higher enzyme concentrations working faster and producing more dephosphorylated peptide.
  • the fluorescein bonded to the now dephosphorylated peptide exhibits a shorter lifetime.
  • FIG. 1 also shows that when the enzyme concentration is very low, the state of phosphorylation is not altered significantly; on the other hand when the highest concentrations are used by adding still more enzymes, no additional effect can be demonstrated.
  • the entire substrate of the sample was converted during the incubation period, so that the proportion of the manifest enzyme function is apparent in the center.
  • FIG. 1 is based on data for the dephosphorylation of Panvera tracer P2843 at various phosphatase concentrations. The error bars were produced from three independent measurements. The unbroken line is only to assist appreciation of dependency. The position of this line moves to the right when the incubation period is shorter and to the left when the period is longer.
  • the z′ value for the data set shown in FIG. 1 is 0.62.
  • FIG. 2 shows the time-dependent nature of the enzyme reaction, i.e. the enzyme kinetics for various enzyme concentrations. Without enzymes the lifetime signal remains stable, i.e. no dephosphorylation occurs. When there is a moderate concentration one can see the entire process in the selected 6-minute period, and for very high concentrations the reaction occurs too quickly to be measurable in this experiment.
  • the measurement points for the various enzyme concentrations are shown as diamonds (without enzymes), triangles (1 nM), squares (3 nM) or spots (30 nM).
  • an enzyme reaction involving the phosphorylation or dephosphorylation of a peptide is of major biological and pharmacological significance.
  • the present invention provides a novel method for analyzing and representing such important processes.
  • preferred applications of the method in accordance with the invention include drug discovery screening, that is the discovery, research, optimization or validation and/or the detection of pharmacologically effective substances and/or in conjunction with the corresponding production of pharmaceutical preparations.
  • attaching phosphate groups to a biomolecule must have a direct impact upon the fluorescent dye.
  • both groups have to be either in the vicinity of each other or the effect can be translated by means of the conformational transformation of biomolecules, which then modifies the molecular environment of the dye.
  • Both chemical units, the phosphate group as well as the dye have to be attached to the same biomolecule, for instance covalently.
  • the biomolecule can also consist of several subunits, that is (hetero or homo) dimers, trimers, or in general oligomers. In this case the two residues can also be located on different subunits of the same biomolecule.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US10/820,404 2003-04-10 2004-04-08 Direct phosphorylation state monitoring on biomolecules Expired - Fee Related US7223610B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH20030653/03 2003-04-10
CH6532003 2003-04-10

Publications (2)

Publication Number Publication Date
US20040259183A1 US20040259183A1 (en) 2004-12-23
US7223610B2 true US7223610B2 (en) 2007-05-29

Family

ID=32855168

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/820,404 Expired - Fee Related US7223610B2 (en) 2003-04-10 2004-04-08 Direct phosphorylation state monitoring on biomolecules

Country Status (5)

Country Link
US (1) US7223610B2 (de)
EP (1) EP1467211B1 (de)
JP (1) JP2005095144A (de)
AT (1) ATE393915T1 (de)
DE (1) DE502004006979D1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070042500A1 (en) * 2003-10-18 2007-02-22 Bayer Healthcare Ag Direct observation of molecular modifications in biological test systems by measuring flourescence lifetime

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042214A1 (en) 1999-01-15 2000-07-20 Pantherix Ltd. Phosphate release enzyme assay
WO2000072016A1 (en) 1999-05-21 2000-11-30 Caliper Technologies Corp. Fluorescence polarization assays involving polyions
US6410255B1 (en) 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0208987D0 (en) * 2002-04-19 2002-05-29 Amersham Biosciences Uk Ltd Methods for measuring protein kinase and phosphatase activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042214A1 (en) 1999-01-15 2000-07-20 Pantherix Ltd. Phosphate release enzyme assay
US6410255B1 (en) 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
WO2000072016A1 (en) 1999-05-21 2000-11-30 Caliper Technologies Corp. Fluorescence polarization assays involving polyions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Fowler et al. Analytical Biochemistry 2002;308:223-231. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070042500A1 (en) * 2003-10-18 2007-02-22 Bayer Healthcare Ag Direct observation of molecular modifications in biological test systems by measuring flourescence lifetime

Also Published As

Publication number Publication date
ATE393915T1 (de) 2008-05-15
EP1467211B1 (de) 2008-04-30
EP1467211A1 (de) 2004-10-13
DE502004006979D1 (de) 2008-06-12
US20040259183A1 (en) 2004-12-23
JP2005095144A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
Hynes et al. Fluorescence-based cell viability screening assays using water-soluble oxygen probes
CN106290917B (zh) 用于检测蛋白质的变构调节剂的方法
US20090227043A1 (en) Fluorescence Resonance Energy Transfer Assay Based on Modified Solid Surface
Sittampalam et al. High-throughput screening: advances in assay technologies
Zaman et al. Fluorescence assays for high-throughput screening of protein kinases
Li et al. Fluorescence detection techniques for protein kinase assay
Unger-Angel et al. Protein recognition by bivalent,‘turn-on’fluorescent molecular probes
JP5085320B2 (ja) 生体反応又は生体内状態変化の複数同時解析法
Long et al. Compact quantitative optic fiber-based immunoarray biosensor for rapid detection of small analytes
EP2812698B1 (de) Zeitaufgelöstes fret mit doppeltem akzeptor
US20160356767A1 (en) Methods for detecting allosteric modulators of protein
Cronk et al. High-throughput screening
Kondoh et al. Construction and application of a photo-cross-linked chemical array
US9146233B2 (en) Detecting molecular interactions by fluorescence resonance energy transfer on a solid-phase support
US7223610B2 (en) Direct phosphorylation state monitoring on biomolecules
JP2005509859A (ja) タグ標識された微粒子組成物および方法
KR20060105747A (ko) 형광 수명 측정에 의한 생물학적 시험 시스템 중 분자개질의 직접적인 관찰
Gubaev et al. Fluorescence resonance energy transfer as a tool to investigate RNA structure and folding
Sergienko et al. Experimental Approaches to Rapid Identification, Profiling, and Characterization of Specific Biological Effects of DOS Compounds
JP2006512905A (ja) ポリ（ａｄｐ−リボース）ポリメラーゼ（ｐａｒｐ）の活性を減少させる化合物を検定する方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: TECAN TRADING AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DOERING, KLAUS;REEL/FRAME:015714/0915

Effective date: 20040505

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20190529